PostEra vs TextSynth
PostEraDrug Discovery Platforms
CustomPublished price
TextSynthGenerative AI Platforms
From $0.10 / 1M input tokensPublished price
PostEra Drug Discovery Platforms Medicinal Chemistry Powered by Machine Learning | TextSynth Generative AI Platforms Access to large language and generative models via REST API | |
|---|---|---|
| Overview | ||
| Category | Drug Discovery Platforms | Generative AI Platforms |
| What it is | AI-powered medicinal chemistry platform that accelerates drug design through synthesis-aware generative chemistry and retrosynthesis. | Fabrice Bellard's API for accessing large language and text-to-image models at competitive pricing. |
| Pricing | ||
| Published price | Custom No public pricing; partnership/collaboration-based. PostEra engages pharma partners under drug-discovery deals (with Pfizer, Amgen and others) rather than a self-serve subscriptio… | From $0.10 / 1M input tokens TextSynth has a rate-limited free plan; paid API pricing starts at $0.10 per million embedding input tokens, while language-model input starts at $0.20 per million tokens. The min… |
| Pricing model | Custom quote | Not available |
| Free options | No free plan · No free trial | Free plan · Free trial |
| Deal on Cubbie | None right now | None right now |
| Company | ||
| Founded | 2019 | 2022 |
| Team size | 51-200 employees | 1-10 employees |
| Headquarters | Boston, MA | Paris, France |